Drug Approval | June 22, 2023
Lupin receives USFDA approval for Tiotropium Dry Powder Inhaler
This product will be manufactured at Lupin's Pithampur facility in India
This product will be manufactured at Lupin's Pithampur facility in India
The booster vaccine can be administered safely to individuals who have received two doses of either Covaxin or Covishield
Dignitaries and delegates commend India’s leadership in Global South during G20 India Presidency
The partnership aims to prioritize the diagnosis and treatment of these diseases while working to reducing their long-term prevalence
Sajjan India Limited is looking for expansion, both organically and through acquisitions, to achieve the planned growth
This trial is a multi-national, phase 2/3, open-label, randomized, controlled clinical study of utidelone injectable
Approximately 60 to 78% of individuals diagnosed with Asthma also have concurrent Allergic Rhinitis
Thiamine Hydrochloride Injection USP had estimated annual sales of USD 35 million in the U.S.
Columvi is part of Roche's industry-leading portfolio of T-cell engaging bispecific antibodies in non-Hodgkin lymphoma, which also includes the recently approved Lunsumio to treat follicular lymphoma
Despite nearly 20 years of availability, biosimilars show worldwide adoption rate of only 14% in initiative-tracked countries, while reference medicines still represent 86% of biologic
Subscribe To Our Newsletter & Stay Updated
